OptimizeRx Corporation
Символ: OPRX
NASDAQ
11.12
USDРыночная цена сегодня
-11.1834
Коэффициент P/E
-0.3338
PEG Ratio
203.16M
Капитал MRK
- 0.00%
Доходность DIV
OptimizeRx Corporation (OPRX) финансовые отчеты
Балансовый отчет
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 155.31 | 13.9 | 74.1 | 84.7 | |||||||||||||||||
balance-sheet.row.short-term-investments | 106.55 | 0 | 55.9 | 0 | |||||||||||||||||
balance-sheet.row.net-receivables | 107.19 | 37.3 | 22.2 | 24.8 | |||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 1.8 | -5630649.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 12.64 | 3.2 | 0.5 | 5630655 | |||||||||||||||||
balance-sheet.row.total-current-assets | 275.15 | 54.3 | 98.6 | 115.1 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1.86 | 0.7 | 0.4 | 0.5 | |||||||||||||||||
balance-sheet.row.goodwill | 202.06 | 78.4 | 22.7 | 14.7 | |||||||||||||||||
balance-sheet.row.intangible-assets | 123.76 | 49.4 | 13 | 10.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 325.82 | 127.8 | 35.7 | 25.4 | |||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | -34.08 | 0.6 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 329.85 | 129 | 36.1 | 25.9 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 604.99 | 183.4 | 134.7 | 141 | |||||||||||||||||
balance-sheet.row.account-payables | 8.12 | 2.2 | 5.5 | 5 | |||||||||||||||||
balance-sheet.row.short-term-debt | 6 | 2.2 | 0.1 | 0.1 | |||||||||||||||||
balance-sheet.row.tax-payables | 0.37 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 66.76 | 34.2 | 0.1 | 0.2 | |||||||||||||||||
Deferred Revenue Non Current | -4.02 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 8.67 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 32.02 | 13.3 | 2.6 | 2.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 76.12 | 38.9 | 0.1 | 0.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0.85 | 0.4 | 0.2 | 0.3 | |||||||||||||||||
balance-sheet.row.total-liab | 123.98 | 56.8 | 8.5 | 9.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 0.08 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.retained-earnings | -252.78 | -64.3 | -46.7 | -35.3 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 733.72 | 190.8 | 172.8 | 166.6 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 481.01 | 126.6 | 126.1 | 131.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 604.99 | 183.4 | 134.7 | 141 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 481.01 | 126.6 | 126.1 | 131.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 604.99 | - | - | - | |||||||||||||||||
Total Investments | 106.55 | 0 | 55.9 | 0 | |||||||||||||||||
balance-sheet.row.total-debt | 73.45 | 36.8 | 0.2 | 0.3 | |||||||||||||||||
balance-sheet.row.net-debt | 24.69 | 23 | -18 | -84.4 |
Отчет о движении денежных средств
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -18.07 | -17.6 | -11.4 | 0.4 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 3 | 2.4 | 2 | 2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | -7695.37 | -7695.4 | 0 | 0.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 12.36 | 13.7 | 15.7 | 5.5 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -12.28 | -15.5 | 4 | -7.3 | |||||||||||||||||
cash-flows.row.account-receivables | -6.2 | -8.7 | 2.3 | -7 | |||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | -0.8 | |||||||||||||||||
cash-flows.row.account-payables | -1.3 | -1.3 | 0.6 | -0.6 | |||||||||||||||||
cash-flows.row.other-working-capital | -4.77 | -5.5 | 1.1 | 1.1 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 7704.66 | 7705.1 | 0.4 | 0.1 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -5.03 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.8 | -0.9 | -0.2 | -0.5 | |||||||||||||||||
cash-flows.row.acquisitions-net | -79.03 | -80.4 | -2 | 0 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -162720.58 | -162.8 | -55.9 | 0 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 163.11 | 218.7 | 2163.6 | 0 | |||||||||||||||||
cash-flows.row.other-investing-activites | 162613.24 | 0 | -2163.6 | 0 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -23.94 | -25.3 | -58.2 | -0.5 | |||||||||||||||||
cash-flows.row.debt-repayment | -36.52 | -36 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-issued | -0.04 | 0.2 | 70671.5 | 70.7 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -7.99 | -7.8 | -20 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0.08 | 35742.2 | -70670.5 | 3.3 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 27.71 | 28.2 | -19 | 73.9 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -4351.9 | 0 | 0 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -1.27 | -4.4 | -66.5 | 74.2 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 48.76 | 13.9 | 18.2 | 84.7 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 50.03 | 18.2 | 84.7 | 10.5 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -5.03 | -7.2 | 10.7 | 0.7 | |||||||||||||||||
cash-flows.row.capital-expenditure | -0.8 | -0.9 | -0.2 | -0.5 | |||||||||||||||||
cash-flows.row.free-cash-flow | -5.84 | -8.1 | 10.4 | 0.2 |
Строка отчета о прибылях и убытках
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 78.21 | 71.5 | 62.5 | 61.3 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 31.6 | 28.6 | 23.5 | 25.7 | |||||||||||||||||
income-statement-row.row.gross-profit | 46.6 | 42.9 | 39 | 35.6 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0.07 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 60.15 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -0.46 | 0.5 | 2 | 2.1 | |||||||||||||||||
income-statement-row.row.operating-expenses | 62.09 | 60.4 | 51.3 | 35.3 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 93.7 | 89 | 74.7 | 60.9 | |||||||||||||||||
income-statement-row.row.interest-income | 1.55 | 2.2 | 0.9 | 0 | |||||||||||||||||
income-statement-row.row.interest-expense | -786.75 | 1.5 | 0.9 | 0 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -14.13 | -8.4 | 0.9 | -0.1 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.46 | 0.5 | 2 | 2.1 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -14.13 | -8.4 | 0.9 | -0.1 | |||||||||||||||||
income-statement-row.row.interest-expense | -786.75 | 1.5 | 0.9 | 0 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 3 | 2.4 | 2 | 2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | -18.67 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -24.37 | -26.4 | -12.3 | 0.5 | |||||||||||||||||
income-statement-row.row.income-before-tax | -25.32 | -25.2 | -11.4 | 0.4 | |||||||||||||||||
income-statement-row.row.income-tax-expense | -7.25 | -7.6 | -0.9 | 0.1 | |||||||||||||||||
income-statement-row.row.net-income | -18.07 | -17.6 | -10.6 | 0.3 |
Часто задаваемые вопросы
Что такое OptimizeRx Corporation (OPRX) общие активы?
OptimizeRx Corporation (OPRX) общие активы - 183373898.000.
Какова годовая выручка предприятия?
Годовая выручка - 48058946.000.
Какова норма прибыли компании?
Норма прибыли компании - 0.596.
Что такое свободный денежный поток компании?
Свободный денежный поток - -0.321.
Что такое норма чистой прибыли предприятия?
Норма чистой прибыли - -0.231.
Что такое общий доход компании?
Общая выручка - -0.312.
Что такое OptimizeRx Corporation (OPRX) чистая прибыль (чистый доход)?
Чистая прибыль (чистый доход) - -17565866.000.
Что такое общий долг компании?
Общий долг - 36823800.000.
Что такое операционные расходы?
Операционные расходы - 60421732.000.
Какова цифра денежных средств компании?
Денежные средства предприятия - 15177000.000.